HOME Research Insight Danaher (US),Bio-Rad (US) and Agilent (US) are Some of the Leading Players in the Microfluidics Market



Danaher (US),Bio-Rad (US) and Agilent (US) are Some of the Leading Players in the Microfluidics Market


The global microfluidics market is projected to reach USD 27.91 Billion by 2023 from USD 10.06 Billion in 2018, at a CAGR of 22.6%. The microfluidics industry is booming market with regional and multinational market players. Danaher (US), Thermo Fisher (US), and Agilent (US) are some of the major players providing microfluidics equipment, while Dolomite Microfluidics (UK) is the provider of microfluidics components.

Danaher (US) is one of the leading players in the microfluidics market. Danaher designs, manufactures, and markets medical, industrial, and commercial products and services. The company operates in the microfluidics market through its subsidiaries such as Cepheid (US) Beckman Coulter, Inc. (US), AB Sciex LLC (US), and Molecular Devices, LLC (US). The company provides a diversified and strong product portfolio of equipment and medical devices integrated with microfluidics technologies. The company continuously focuses on R&D activities with growing investments in product development which is evident from the rising R&D expenditure of the company from USD 861.4 million in 2015 to USD 1,128.8 million in 2017. Moreover, the company has strategically enhanced its presence in the global microfluidics market by pursuing a number of inorganic and organic growth strategies such as acquisitions. For instance, in November 2016, the company acquired Cepheid Inc. (US), a leading and innovative global molecular diagnostics company, thus strengthening Danaherís portfolio with its GeneXpert systems.

Bio-Rad (US) serves life sciences research and clinical diagnostics customers worldwide through its global network of operations. The Life Sciences segment develops, manufactures, and markets more than 5,000 reagents, apparatus, and laboratory instruments, globally. The company provides microfluidic solutions under the Life Sciences segment. The company also has a wide geographical presence with direct distribution channels in more than 30 countries, which enables it to maintain a strong customer base. Bio-Rad has manufacturing and R&D facilities in the US, France, China, Germany, Singapore, Belgium, and Switzerland. The company pursues the strategies of acquisition to strengthen its presence in the microfluidics market. It also aims at introducing technologically advanced products to cater to the changing customer needs. In 2017, Bio-Rad acquired RainDance Technologies (US), a developer of microfluidic-based PCR systems. This enabled Bio-Rad to offer technologically advanced microfluidic equipment to its customers and strengthen its existing portfolio.

Agilent (US) is a global player in the life sciences market with a wide geographical presence across North America, Asia Pacific, and Europe. The company is well-positioned in the microfluidics market and focuses on developing innovative diagnostic and research equipment to combat the rise in infectious diseases and cancer. In accordance with this, the company established a strong network of research organizations including government research centers and top-tier universities. It has its research centers based in Santa Clara and California (US), with offices in Europe and Asia. Agilent generated about 70% of its revenues outside the US. Thus, the diversified geographic presence offers the company more avenues for attaining significant revenue growth.

Related Reports:

Microfluidics Market by Application (Genomics, Proteomics, Capillary Electrophoresis, IVD (POC, Clinical Diagnostics), Drug Delivery, Microreactor, Lab Tests), Component (Chips, Pump, Needle), Material (Polymer, Glass, Silicon) - Global Forecast to 2023

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports